Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Nu Holdings
NU
|
$652M |
| 2 |
Symbotic
SYM
|
$427M |
| 3 |
Coupang
CPNG
|
$411M |
| 4 |
Meta Platforms (Facebook)
META
|
$363M |
| 5 |
Mobileye
MBLY
|
$243M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.14B |
| 2 |
Spotify
SPOT
|
$579M |
| 3 |
Broadridge
BR
|
$577M |
| 4 |
Mercado Libre
MELI
|
$524M |
| 5 |
Charles Schwab
SCHW
|
$501M |
Sector Composition
| 1 | Technology | 28.97% |
| 2 | Consumer Discretionary | 27.33% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 14.03% |
| 5 | Financials | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Progyny
PGNY
$2.03B
| $42.4M | 0.03% |
1,110,107
-18,366
| -2% | -$701K |
|
152
Twist Bioscience
TWST
$1.55B
| $42.1M | 0.03% |
1,227,528
+132,770
| +12% | +$4.56M |
|
153
Medtronic
MDT
$119B
| $41.2M | 0.03% |
472,655
-6,089
| -1% | -$531K |
|
154
American Tower
AMT
$91.4B
| $40.5M | 0.03% |
205,119
+8,359
| +4% | +$1.65M |
|
155
Home Depot
HD
$410B
| $40.3M | 0.03% |
104,929
+42,001
| +67% | +$16.1M |
|
156
Vir Biotechnology
VIR
$714M
| $40M | 0.03% |
3,947,065
-18,484
| -0.5% | -$187K |
|
157
Eversource Energy
ES
$23.5B
| $39.4M | 0.03% |
659,420
-8,559
| -1% | -$512K |
|
158
BlackLine
BL
$3.28B
| $39.3M | 0.03% |
608,465
-51,816
| -8% | -$3.35M |
|
159
MP Materials
MP
$11.4B
| $39.2M | 0.03% |
2,743,455
-216,546
| -7% | -$3.1M |
|
160
Dolby
DLB
$6.98B
| $38.7M | 0.03% |
462,473
-13,079
| -3% | -$1.1M |
|
|
ZUO
161
DELISTED
Zuora, Inc.
ZUO
| $38.3M | 0.03% |
4,201,954
-242,911
| -5% | -$2.22M |
|
162
Edwards Lifesciences
EW
$47.5B
| $37.9M | 0.03% |
396,553
-7,405
| -2% | -$708K |
|
163
CyberArk
CYBR
$23.1B
| $37.1M | 0.03% |
139,481
-4,034
| -3% | -$1.07M |
|
164
UnitedHealth
UNH
$281B
| $36.1M | 0.03% |
72,956
-3,803
| -5% | -$1.88M |
|
165
New York Times
NYT
$9.64B
| $35.6M | 0.03% |
823,139
-45,319
| -5% | -$1.96M |
|
166
NextEra Energy, Inc.
NEE
$146B
| $34.7M | 0.03% |
542,915
-86,783
| -14% | -$5.55M |
|
167
American Superconductor
AMSC
$2.19B
| $34.1M | 0.03% |
2,526,550
+440,271
| +21% | +$5.95M |
|
168
Zoom
ZM
$24.8B
| $33.1M | 0.03% |
506,036
-522,043
| -51% | -$34.1M |
|
169
McDonald's
MCD
$226B
| $32.7M | 0.03% |
116,102
-1,851
| -2% | -$522K |
|
170
NovoCure
NVCR
$1.34B
| $31.1M | 0.02% |
1,990,375
-2,849,766
| -59% | -$44.5M |
|
171
Rexford Industrial Realty
REXR
$9.96B
| $30M | 0.02% |
597,055
-36,987
| -6% | -$1.86M |
|
172
IPG Photonics
IPGP
$3.48B
| $29.6M | 0.02% |
326,135
-223
| -0.1% | -$20.2K |
|
173
Pacira BioSciences
PCRX
$1.2B
| $29.2M | 0.02% |
1,000,774
-62,492
| -6% | -$1.83M |
|
174
Hershey
HSY
$37.6B
| $28M | 0.02% |
144,003
+51,716
| +56% | +$10.1M |
|
175
CRISPR Therapeutics
CRSP
$4.8B
| $27M | 0.02% |
395,915
-26,848
| -6% | -$1.83M |
|